メニュー →
サイト内検索結果 「」
全16,671件中、3,641件~3,660件を表示しています。
[1] ・・・ [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] ・・・ [834]
[1] ・・・ [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] ・・・ [834]
7281.
[生薬成分の代謝] 代謝物『(8S,9S,10R,13R,14S,17R)-17-(heptan-2-yl)-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one』
(8S,9S,10R,13R,14S,17R)-17-(heptan-2-yl)-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one (8S,9S,10R,13R,14S,17R)-17-(heptan-2-yl)-10,13-dimethyl-6,7,8,
7282.
[生薬成分の代謝] 代謝物『Cholesterol』
(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol Cholesterol 57-88-5 C27H46O 386.662 386.3549 387.
7283.
[生薬成分の代謝] 代謝物『(3S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-17-(6-methylheptan-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthren-3-ol』
(3S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-17-(6-methylheptan-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthren-3-ol (3S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-17-(6-methylheptan-2-yl)hexadecahydro-1H-cycl
7284.
[生薬成分の代謝] 代謝物『Cholic acid』
(R)-4-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid Cholic acid 81-25-4 C24H40O5 408.579 408.2876 409.2954 407.27
7285.
[生薬成分の代謝] 代謝物『(R)-4-((3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid』
(R)-4-((3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid (R)-4-((3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethylh
7286.
[生薬成分の代謝] 代謝物『(R)-4-((7R,8S,9S,10R,13R,14S,17R)-7-hydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid』
(R)-4-((7R,8S,9S,10R,13R,14S,17R)-7-hydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid (R)-4-((7R,8S,9S,10R,13R,14S,17R)-7
7287.
[生薬成分の代謝] 代謝物『(R)-4-((8S,9S,10R,13R,14S,17R)-10,13-dimethyl-3-oxo-2,3,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid』
(R)-4-((8S,9S,10R,13R,14S,17R)-10,13-dimethyl-3-oxo-2,3,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid (R)-4-((8S,9S,10R,13R,14S,17R)-10,13-dimethyl-3-oxo-2,3
7288.
[生薬成分の代謝] 代謝物『(R)-4-((5R,7R,8R,9S,10S,13R,14S,17R)-7-hydroxy-10,13-dimethyl-3-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid』
(R)-4-((5R,7R,8R,9S,10S,13R,14S,17R)-7-hydroxy-10,13-dimethyl-3-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid (R)-4-((5R,7R,8R,9S,10S,13R,14S,17R)-7-hydroxy-10,13-dimethyl-3-oxohex
7289.
[生薬成分の代謝] 代謝物『(2R,3R)-2,3-bis(3-hydroxybenzyl)butane-1,4-diol』
(2R,3R)-2,3-bis(3-hydroxybenzyl)butane-1,4-diol (2R,3R)-2,3-bis(3-hydroxybenzyl)butane-1,4-diol 80226-00-2 C18H22O4 302.37 302.1518 303.1596 301.144 Enterodiol 代謝物
7290.
[生薬成分の代謝] 代謝物『(+)-Enterolactone (2S, 3S)』
(3S,4S)-3,4-bis(3-hydroxybenzyl)dihydrofuran-2(3H)-one (+)-Enterolactone (2S, 3S) C18H18O4 298.339 298.1205 299.1283 297.1127 Enterodiol 代謝物
7291.
[生薬成分の代謝] 代謝物『(+)-Enterolactone (2R, 3R)』
(3R,4R)-3,4-bis(3-hydroxybenzyl)dihydrofuran-2(3H)-one (+)-Enterolactone (2R, 3R) C18H18O4 298.339 298.1205 299.1283 297.1127 Enterodiol 代謝物
7292.
[生薬成分の代謝] 代謝物『(-)-Enterodiol (2R, 3R)』
(2R,3R)-2,3-bis(3-hydroxybenzyl)butane-1,4-diol (-)-Enterodiol (2R, 3R) C18H22O4 302.37 302.1518 303.1596 301.144 Enterodiol 代謝物
7293.
[生薬成分の代謝] 代謝物『(2S,3S)-2,3-bis(3-hydroxybenzyl)butane-1,4-diol』
(2S,3S)-2,3-bis(3-hydroxybenzyl)butane-1,4-diol (2S,3S)-2,3-bis(3-hydroxybenzyl)butane-1,4-diol C18H22O4 302.37 302.1518 303.1596 301.144 Enterodiol 代謝物
7294.
[生薬成分の代謝] 代謝物『(+)-Enterodiol (2S, 3S)』
(2S,3S)-2,3-bis(3-hydroxybenzyl)butane-1,4-diol (+)-Enterodiol (2S, 3S) C18H22O4 302.37 302.1518 303.1596 301.144 Enterodiol 代謝物
7295.
[生薬成分の代謝] 代謝物『Strophanthidin』
(3S,5S,8R,9S,10S,13R,14S,17R)-3,5,14-trihydroxy-13-methyl-17-(5-oxo-2,5-dihydrofuran-3-yl)hexadecahydro-1H-cyclopenta[a]phenanthrene-10-carbaldehyde Strophanthidin 66-28-4 C23H32O6 404.503 404.2199 40
7296.
[生薬成分の代謝] 代謝物『(-)-Enterodiol』
(2R,3R)-2,3-bis(3-hydroxybenzyl)butane-1,4-diol (-)-Enterodiol 80226-00-2 C18H22O4 302.37 302.1518 303.1596 301.144 Secoisolariciresinol 代謝物
7297.
[生薬成分の代謝] 代謝パラメータ『Intravenous administration』
Intravenous administration 10 mg/kg (n=7) 25.1 ± 10.9 7.5 ± 4.6 min 197.9 ± 46.7* ng/mL 7.69 ± 3.56* μg・min/mL * The values were significantly different from 2 and 5 mg/kg (p
7298.
[生薬成分の代謝] 代謝パラメータ『Intravenous administration』
Intravenous administration 10 mg/kg (n=6) 16.6 ± 3.6 Vss 542 ± 85.1 mL/kg 56.7 ± 8.5* mL/min/kg
CLR 2.8 ± 1.0 mL/min/kg
CLNR 54.6 ± 9.9* mL/min/kg 179.4 ± 24.5* μg・min/mL 0-∞ 9.1 ± 1.1 min
7299.
[生薬成分の代謝] 代謝物『3,4-dihydroxybenzoic acid』
3,4-dihydroxybenzoic acid 3,4-dihydroxybenzoic acid 99-50-3 C7H6O4 154.122 154.0266 155.0344 153.0188 Quinic acid 代謝物
7300.
[生薬成分の代謝] 代謝パラメータ『Intravenous administration』
Intravenous administration 5 mg/kg (n=6) 55.0 ± 58.1 2.3 ± 2.1 min 172.3 ± 46.9 ng/mL 6.38 ± 3.69 μg・min/mL Isovanilloylcatalpol 代謝パラメータ
[1]
・・・
[178]
[179]
[180]
[181]
[182]
[183]
[184]
[185]
[186]
[187]
[188]
・・・
[834]
全16,671件中、3,641件~3,660件を表示しています。
全16,671件中、3,641件~3,660件を表示しています。